Wei Ding

Associate Professor of Medicine, Consultant

Mayo Clinic Minnesota

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Esteban Braggio

Assistant Professor

Mayo Clinic

UNITED STATES

View details

David Bearss

UNITED STATES

View details

Rick Kennedy

Professor of Medicine

Mayo Clinic

UNITED STATES

View details

Scott F Huntington

Yale University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wei Ding

Research Interests

Explore related searches

Contact this professor

Articles (10)

Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment

DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib

Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis

Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index

The prognostic significance of del6q23 in chronic lymphocytic leukemia

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance

Collaborators (4)

Esteban Braggio

David Bearss

Rick Kennedy

Scott F Huntington

Make your next move.